| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/27/2002 | US20020081595 Nucleotide sequences coding preferential polypeptide for use in humantherapeutics and diagnostics |
| 06/27/2002 | US20020081593 Screening heredity of preferential shellfish; obtain shellfish, extract mitochondrial nucleotide sequences, sequence nucleotide sequence, compare to other shellfish |
| 06/27/2002 | US20020081592 Reproduction-specific genes |
| 06/27/2002 | US20020081591 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
| 06/27/2002 | US20020081590 Microarray for use in the detection of preferential genes in sample |
| 06/27/2002 | US20020081589 Gene expression monitoring using universal arrays |
| 06/27/2002 | US20020081588 Biosensor for use in the detection of perferential compounds in sample; for use tool in human therapeutics |
| 06/27/2002 | US20020081585 Compounds for detection an inflammatory bowel disease |
| 06/27/2002 | US20020081584 Nucleotide sequences coding preferential polypeptide for use in the diagnosis, prevention and treatment of schizophrenia |
| 06/27/2002 | US20020081582 Making multimers such as DNA or peptides in chemical reactor by solution-based photochemical reactions involving reagents generated in situ by irradiation |
| 06/27/2002 | US20020081581 Compositions and methods for reverse transcription of nucleic acid molecules |
| 06/27/2002 | US20020081580 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081577 Synthetic oligonucleotide for use in the prevention of viral disease |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081574 Enzymatic polypeptide for use in the diagnosis, prevention and treatment of viral disease |
| 06/27/2002 | US20020081570 System to detect protein-protein interactions |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081317 Bacteria rendered non-pathogenic having altered DNA adenine methylase activity, genetically engineered to express a heterologous antigen such as immunogenic antigen of a virus, protozoa, parasite or fungi |
| 06/27/2002 | US20020081316 Vector and recombinant vaccines made therefrom useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease |
| 06/27/2002 | US20020081313 Antibodies; protecting animals from diseases caused by filariids; fluorescent or colorimetric tagged enzyme substrate |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | US20020081309 Conjugating a protein with polyethylene glycol (PEG), by deleting amino residue(s); for example, replacing protein arginine residues with lysine residues that provide a PEG attachment site; bioactivity |
| 06/27/2002 | US20020081304 Type f botulinum toxin and use thereof |
| 06/27/2002 | US20020081297 Co-administering to the mammal a recombinant virus comprising a transgene and an immune modulator which inhibits the formation of neutralizing antibodies to the recombinant virus |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081284 Manipulation of arterial-venous identity |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/27/2002 | US20020081280 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | US20020081012 Image analyzing method and apparatus |
| 06/27/2002 | US20020080424 Digital data producing system |
| 06/27/2002 | US20020080350 GigaMatrix holding tray having through-hole wells |
| 06/27/2002 | US20020079846 Novel glutathione-S-transferase nucleic acids and polypeptides and methods of use thereof |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2439509A1 Equine ige-allotype |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433048A1 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432992A1 Fab i and inhibition of apicomplexan parasites |
| 06/27/2002 | CA2432785A1 Seleno-cysteine containing protein zsel1 |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432744A1 Novel cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 06/27/2002 | CA2432737A1 Human ion channel protein and polynucleotides encoding the same |
| 06/27/2002 | CA2432506A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432301A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431994A1 Method for the production of polyfructans |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431898A1 Compositions, methods and kits for identifying protein-protein interaction disrupting agents |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431884A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 06/27/2002 | CA2431882A1 Method for detecting whether an organism is homozygous or heterozygous using labelled primers and rflp |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430782A1 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | CA2430475A1 Methods and cells for detecting modulators of rgs proteins |
| 06/27/2002 | CA2429519A1 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | CA2327581A1 Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules |
| 06/26/2002 | EP1217376A1 Beads |
| 06/26/2002 | EP1217081A2 Methods and reagents for detecting increased risk of developing an inflammatory disorder |
| 06/26/2002 | EP1217080A2 Methods, compositions and kits relating to cardiovascular disease |
| 06/26/2002 | EP1217077A2 Novel bioluminescent assays and bacterial strains useful therein |
| 06/26/2002 | EP1217074A1 Nucleic acid integration in eukaryotes |
| 06/26/2002 | EP1217073A2 Transformed plants with improved tolerance to phosphomethylglycine family herbicides containing a gene encoding a mutated 5-enolpyruvylshikimate-3-phophate synthase |
| 06/26/2002 | EP1217072A2 Method of the preparation of an expression vector for the production of therapeutic proteins in transgenic animals |
| 06/26/2002 | EP1217071A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 06/26/2002 | EP1217070A1 Selective cytotoxic fusion proteins |
| 06/26/2002 | EP1217069A2 Nucleotide sequences which code for the ilvE gene |
| 06/26/2002 | EP1217068A2 Oil palm (genus Elaeis) peroxiredoxin gene and uses thereof |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1217006A2 Polypeptides and nucleic acids encoding the same |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216619A2 Method for the preparation of a cheese product |
| 06/26/2002 | EP1216618A1 Cheese product and method for the preparation thereof |
| 06/26/2002 | EP1216411A1 Method and device for detecting a molecular recognition reaction |
| 06/26/2002 | EP1216309A2 Methods for targeting rna molecules |
| 06/26/2002 | EP1216308A2 Oxygenase enzymes and screening method |
| 06/26/2002 | EP1216306A1 Commercial production of chymosin in plants |
| 06/26/2002 | EP1216305A1 Lactobacillus delbruckii strain and its use for screening plasmids |
| 06/26/2002 | EP1216304A1 Whole cell catalyst comprising a hydantoinase, a racemase and a carbamoylase |
| 06/26/2002 | EP1216303A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216301A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216299A2 Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 06/26/2002 | EP1216298A2 Methods of producing cloned and transgenic mammals |
| 06/26/2002 | EP1216297A2 Double transgenic animals as models for neurodegenerative disease |
| 06/26/2002 | EP1216259A1 SIGNAL SEQUENCES FOR THE PRODUCTION OF LEU-HIRUDINE VIA SECRETION BY i E. COLI /i IN A CULTURE MEDIUM |
| 06/26/2002 | EP1216258A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |